Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2003 | 476 | 0.390 |
Why?
|
| DNA Methylation | 5 | 2006 | 2669 | 0.280 |
Why?
|
| Myelodysplastic Syndromes | 5 | 2019 | 2979 | 0.270 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2003 | 1823 | 0.260 |
Why?
|
| Cell Cycle Proteins | 3 | 2003 | 2045 | 0.250 |
Why?
|
| Erwinia | 1 | 2023 | 7 | 0.230 |
Why?
|
| Genes, Tumor Suppressor | 3 | 2003 | 1064 | 0.220 |
Why?
|
| Drug Hypersensitivity | 1 | 2023 | 128 | 0.200 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2003 | 310 | 0.190 |
Why?
|
| Hypersensitivity | 1 | 2023 | 216 | 0.190 |
Why?
|
| Blood Cells | 1 | 2000 | 127 | 0.180 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2019 | 31 | 0.170 |
Why?
|
| Anemia, Aplastic | 1 | 2019 | 214 | 0.150 |
Why?
|
| Bone Marrow Cells | 1 | 2000 | 943 | 0.140 |
Why?
|
| Carrier Proteins | 2 | 2001 | 2022 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 3 | 2003 | 72 | 0.120 |
Why?
|
| Fatigue | 1 | 2019 | 1239 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2000 | 1443 | 0.100 |
Why?
|
| Gene Silencing | 3 | 2006 | 837 | 0.100 |
Why?
|
| Nonprescription Drugs | 1 | 2011 | 52 | 0.100 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2023 | 2796 | 0.090 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2011 | 308 | 0.080 |
Why?
|
| Enzyme Inhibitors | 2 | 2006 | 1879 | 0.080 |
Why?
|
| Methyltransferases | 1 | 2006 | 148 | 0.060 |
Why?
|
| Receptors, Androgen | 2 | 2000 | 878 | 0.060 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2003 | 83 | 0.060 |
Why?
|
| DNA Primers | 2 | 2003 | 1399 | 0.060 |
Why?
|
| Dosage Compensation, Genetic | 2 | 2000 | 63 | 0.060 |
Why?
|
| Asparaginase | 1 | 2023 | 184 | 0.050 |
Why?
|
| CpG Islands | 1 | 2003 | 633 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2001 | 202 | 0.050 |
Why?
|
| Azacitidine | 1 | 2006 | 1149 | 0.050 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2006 | 1299 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 14289 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2000 | 406 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2003 | 3203 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2011 | 2992 | 0.040 |
Why?
|
| Leukemia, Myeloid | 2 | 2001 | 941 | 0.040 |
Why?
|
| Acute Disease | 2 | 2001 | 2422 | 0.040 |
Why?
|
| Cell Cycle | 1 | 2003 | 2084 | 0.040 |
Why?
|
| Escherichia coli | 1 | 2023 | 1203 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2003 | 5395 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 413 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2003 | 2358 | 0.030 |
Why?
|
| DNA, Neoplasm | 1 | 2000 | 1910 | 0.030 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2000 | 1242 | 0.030 |
Why?
|
| Bacitracin | 1 | 2011 | 5 | 0.030 |
Why?
|
| Neomycin | 1 | 2011 | 38 | 0.030 |
Why?
|
| Ointments | 1 | 2011 | 27 | 0.030 |
Why?
|
| DNA | 1 | 2000 | 2693 | 0.030 |
Why?
|
| Anxiety | 1 | 2019 | 1179 | 0.030 |
Why?
|
| Polymyxin B | 1 | 2011 | 53 | 0.020 |
Why?
|
| Exercise | 1 | 2019 | 1183 | 0.020 |
Why?
|
| Pain | 1 | 2019 | 1658 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2001 | 4053 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2019 | 29902 | 0.020 |
Why?
|
| Humans | 8 | 2023 | 261506 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2000 | 4078 | 0.020 |
Why?
|
| Depression | 1 | 2019 | 1715 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 994 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2001 | 4821 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2001 | 5270 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2006 | 515 | 0.020 |
Why?
|
| Quality of Life | 1 | 2019 | 4532 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 70117 | 0.010 |
Why?
|
| Adult | 2 | 2019 | 77950 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 86204 | 0.010 |
Why?
|
| Child | 1 | 2023 | 29154 | 0.010 |
Why?
|
| MDS1 and EVI1 Complex Locus Protein | 1 | 2001 | 52 | 0.010 |
Why?
|
| Neoplasms | 1 | 2006 | 15193 | 0.010 |
Why?
|
| Young Adult | 1 | 2019 | 21445 | 0.010 |
Why?
|
| Female | 3 | 2019 | 141928 | 0.010 |
Why?
|
| Male | 2 | 2019 | 123000 | 0.010 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2001 | 560 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 31252 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 1130 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2001 | 3101 | 0.010 |
Why?
|
| Base Sequence | 1 | 2000 | 4917 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 3154 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2000 | 6100 | 0.010 |
Why?
|
| Disease Progression | 1 | 2001 | 6682 | 0.010 |
Why?
|
| Neoplasm Proteins | 1 | 2001 | 3230 | 0.010 |
Why?
|